MarketsStocksBERLDRG
BE

Beryl Drugs Ltd.

NSE: BERLDRGBSE: 524606Healthcare
Download Research Report7-page PDF
24.65
+7.92%
NSE · auto-updates while market open
Mkt Cap
₹12 Cr
P / E
27.7
P / B
1.2
ROE
4.3%
52W High
₹30.00
52W Low
₹15.92
Key Metrics
Market Cap
₹12 Cr
P / E
27.69
P / B
1.18
EV / EBITDA
7.10
ROCE
7.2%
ROE
4.3%
Debt / Equity
0.24
Book Value
₹19.41
EPS
₹0.30
Div Yield
0.0%
Face Value
-
Promoter Holding
27.5%
Revenue · ₹ Cr
15
FY22
27
FY23
27
FY24
21
FY25
19
FY26
Net Profit · ₹ Cr
1
1
1
0
-1
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹1.5
₹1.5
₹1.1
₹0.3
₹-1.3
FY22FY23FY24FY25FY26
Q1 2026 snapshot
Sales
₹5 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹1.11
Scorecard · 7 axes
Quality
Avg
55/100
Valuation
Avg
27.7×
Growth
Weak
+3.3%
Profitability
Weak
5.8%
Performance
Avg
+17.1%
Entry Point
Avg
82%
Red Flags
Strong
0 flags
Shareholding Pattern
27.5%Promoter
Promoter27.5%
Public72.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue5.45.224.845.163.855.47
Net Profit0.0520.1520.0210.009-0.1680.563
NPM %1.0%2.9%0.4%0.2%-4.4%10.3%
AlertPre-trade